Primary hepatolithiasis, recurrent pyogenic cholangitis, and oriental cholangiohepatitis - A tale of 3 countries

Advances in Anatomic Pathology

Volumn 18, Issue 4, 2011, Pages 318-328

  Tsui, Wilson M S ^a   Lam, Polly W Y ^b   Lee, Wai Ki ^c   Chan, Yiu Kay ^a  

^a Caritas Medical Centre Hong Kong   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^c TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

hepatolithiasis; intrahepatic stone; oriental cholangiohepatitis; recurrent pyogenic cholangitis; sclerosing cholangitis

Indexed keywords

BETA GLUCURONIDASE; BILIRUBIN; BILIRUBIN GLUCURONIDE;

ABDOMINAL PAIN; BACTERIAL INFECTION; BILE COMPOSITION; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILE DUCT STONE; CAROLI DISEASE; CHRONIC INFLAMMATION; CLINICAL FEATURE; DIET; DIFFERENTIAL DIAGNOSIS; ENDOSCOPY; ESCHERICHIA COLI; FEVER; HONG KONG; HUMAN; INTRAHEPATIC BILE DUCT; JAPAN; JAUNDICE; KOREA; LABORATORY DIAGNOSIS; LAPAROSCOPY; LIVER FIBROSIS; LIVER PARENCHYMA; PARASITOSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCLEROSING CHOLANGITIS;

CHOLANGITIS; HEPATITIS; HONG KONG; HUMANS; JAPAN; KOREA; LITHIASIS; TERMINOLOGY AS TOPIC;

EID: 79959193567     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e318220fb75     Document Type: Review

References (79)

1. Cook J, Hou PC, Ho HC, et al. Recurrent pyogenic cholangitis. Br J Surg. 1954;42:188-203.
2. Ong GB. A study of recurrent pyogenic cholangitis. Arch Surg. 1962;84:199-225.
3. Digby KH. Common-duct stones of liver origin. Br J Surg. 1930;17:578-591.
4. Harrison-Levy A. The biliary obstruction syndrome of the Chinese. Br J Surg. 1962;49:674-685.
5. Mage S, Morel AS. Surgical experience with cholangiohepatitis (Hong Kong Disease) in Canton Chinese. Ann Surg. 1965;162:187-190.
6. Stock FE, Fung JH. Oriental cholangiohepatitis. Arch Surg. 1962;84:409-412.
7. Carmona RH, Crass RA, Lim RC, et al. Oriental cholangitis. Am J Surg. 1984;148:117-124. (Pubitemid 14090214)
8. Chou ST, Chan CW. Recurrent pyogenic cholangitis: a necropsy study. Pathology. 1980;12:415-428. (Pubitemid 10025247)
9. Wong J, Choi TK. Recurrent pyogenic cholangitis. In: Okuda K, Nakayama F, Wong J. Intrahepatic Calculi. New York: AR Liss; 1984:175-192.
10. Caroli J. Diseases of the intrahepatic biliary tree. Clin Gastroenterol. 1973;2:147.
11. Saik RP, Greenburg AG, Farris JM, et al. Spectrum of cholangitis. Am J Surg. 1975;130:143.
12. Choi TK. Intrahepatic stones. Surgery. 1989;76:213-214.
13. Nakayama F, Furusawa T, Nakama T. Hepatolithiasis in Japan: present status. Am J Surg. 1980;139:216-220. (Pubitemid 10174734)
14. Ohta G, Nakanuma Y, Terada T. Pathology of hepatolithiasis: cholangitis and cholangiocarcinoma. In: Okuda K, Nakayama F, Wong J, eds. Intrahepatic Calculi. New York: AR Liss; 1984:91-113.
15. Nakanuma Y, Yamaguchi K, Ohta G, et al; the Japanese Hepatolithiasis Study Group. Pathologic Features of Hepatolithiasis in Japan. Human Pathol. 1988;19:1181-1186.
16. Pridgen JE, Aust JB, Innis D. Primary intrahepatic gallstones. Arch Surg. 1977;112:037-1043.
17. Saunders KD, Cates JA, Roslyn JJ. Pathogenesis of gallstones. Surg Clin N Am. 1990;70:1197-1216.
18. Suzuki N, Takahashi W, Sato T. Types and chemical composition of intrahepatic stones. In: Okuda K, Nakayama F,Wong J, eds. Intrahepatic Calculi. New York: AR Liss; 1984:71-80.
19. Kim MH, Sekijima J, Lee SP. Primary intrahepatic stones. Am J Gastroenterol. 1995;90:540-548.
20. Lim JH. Oriental cholangiohepatitis: pathologic, clinical, and radiologic features. Am J Radiol. 1991;157:1-8.
21. Seel DJ, Park YK. Oriental infestational cholangitis. Am J Surg. 1983;146:366-370. (Pubitemid 13001748)
22. Cheung KL, Lai EC. The management of intrahepatic stones. Adv Surg. 1996;29:111-129.
23. Ho CS, Wesson DE. Recurrent pyogenic cholangitis in Chinese immigrants. Am J Radiol. 1974; 122: 368-374.
24. Sperling RM, Koch J, Sandhu J, et al. Recurrent pyogenic cholangitis in Asian immigrants to the United States: natural history and role of therapeutic ERCP. Dig Dis Sci. 1997;42:865-871. (Pubitemid 27196046)
25. Harris HW, Kumwenda ZL, Chen SM, et al. Recurrent pyogenic cholangitis. Am J Surg. 1998;176:34-37. (Pubitemid 28340953)
26. Chen PH, Lo HW, Wang CS, et al. Cholangiocarcinoma in hepatolithiasis. J Clin Gastroenterol. 1984;6:539-547. (Pubitemid 15182121)
27. Chen MF, Jan YY,Wang CS, et al. Intrahepatic stones associated with cholangiocarcinoma. Am J Gastroenterol. 1989;84:391-395.
28. Nakayama F. Hepatolithiasis: an update. J Gastroenterol Hepatol. 1988;3:279-285.
29. Fan ST, Choi TK, Lo CM, et al. Treatment of hepatolithiasis: improvement of result by a systemic approach. Surgery. 1991;109:474-480.
30. Su CH, Lui WY, Peng FK. Relative prevalence of gallstone diseases in Taiwan: a nationwide cooperative study. Dig Dis Sci. 1992;37:764-768.
31. Park YH, Park SJ, Jang JY, et al. Changing patterns of gallstone disease in Korea. World J Surg. 2004;28:206-210.
32. Lo CM, Fan ST, Wong J. The changing epidemiology of recurrent pyogenic cholangitis. Hong Kong Med J. 1997;3:302-304.
33. Tsui WM, Chan YK, Wong CT, et al. Hepatolithiasis and the syndrome of recurrent pyogenic cholangitis: clinical, radiologic and pathologic features. Sem Liver Dis. 2011;31:33-48.
34. Leung JW, Yu AS. Hepatolithiasis and biliary parasites. Baillieres Clin Gastroenterol. 1997;11:681-706. (Pubitemid 28058793)
35. Lim JH, Ko YT, Lee DH, et al. Oriental cholangiohepatitis: sonographic findings in 48 cases. Am J Radiol. 1990;155:511-514. (Pubitemid 20254491)
36. Chau EM, Leong LL, Chan FL. Recurrent pyogenic cholangitis: ultrasound evaluation compared with endoscopic retrograde cholangiopancreatography. Clin Radiol. 1987;38:79-85. (Pubitemid 17206485)
37. Chan FL, Man SW, Leong LL, et al. Evaluation of recurrent pyogenic cholangitis with CT: analysis of 50 patients. Radiology. 1989;170:165-169. (Pubitemid 19016869)
38. Kim MJ, Cha SW, Mitchell DG, et al. MR imaging findings in recurrent pyogenic cholangitis. Am J Radiol. 1999;173:1545-1549.
39. Park MS, Yu JS, Kim KW, et al. Recurrent pyogenic cholangitis: comparison between MR cholangiography and direct cholangiography. Radiology. 2001;220:677-682.
40. Kusano T, Isa T, Ohtsubo M, et al. Natural progression of untreated hepatolithiasis that shows no clinical signs at its initial presentation. J Clin Gastroenterol. 2001;33:114-117. (Pubitemid 32685919)
41. Wu PC. Recurrent pyogenic cholangitis and clonorchiasis. In: Ho FCS, Wu PC, eds. Topics in Pathology for Hong Kong. Hong Kong: Hong Kong University Press. 1995:21-32.
42. Shimada H, Nihmoto S, Matsuba A, et al. Primary cholesterol hepatolithiasis. Gastroentero Jpn. 1989;24:170-176. (Pubitemid 19162228)
43. Saito K, Nakanuma Y, Ohta T, et al. Morphological study of cholesterol hepatolithiasis: report of three cases. J Clin Gastroenterol. 1990;12:585-590. (Pubitemid 20303425)
44. Ohta T, Nagakawa T, Takeda T, et al. Histological evaluation of the intrahepatic biliary tree in intrahepatic cholesterol stones, including immunohistochemical staining against apolipoprotein A-1. Hepatology. 1993;17:531-537. (Pubitemid 23115494)
45. Kondo S, Nimura Y, Hayakawa N, et al. A clinicopathologic study of primary cholesterol hepatolithiasis. Hepatogastroenterology. 1995;42:478-486.
46. Kim SW, Park YH, Choi JW. Clinical and epidemiologic analysis of 10-year experienced 1719 gallstone patients. Korean J Gastroenterol. 1993;25:159-167.
47. Tsui WM, Lam PW, Mak CK, et al. Features of sclerosing cholangitis in recurrent pyogenic cholangitis (Abstract). Int J Surg Pathol. 1995;2S:323.
48. Yoon KH, Ha HK, Lee JS, et al. Inflammatory pseudotumor of the liver in patients with recurrent pyogenic cholangitis: CThistopathologic correlation. Radiology. 1999;211:373-379. (Pubitemid 29206803)
49. Chen MF, Jan YY, Wang CS, et al. A reappraisal of cholangiocarcinoma in patient with hepatolithiasis. Cancer. 1993:71;2461-2465.
50. Tsui WM, Tse CC. Biliary epithelial dysplasia in recurrent pyogenic cholangitis (Abstract). Int J Surg Pathol. 1994;2:205.
51. Chijiiwa K, Ichimiya H, Kuroki S, et al. Late development of cholangiocarcinoma after the treatment of hepatolithiasis. Surg Gynecol Obstet. 1993;177:279-282. (Pubitemid 23262676)
52. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens - Part B: biological agents. Lancet Oncol. 2009;10:321-322.
53. Nakanuma Y, Terada T, Tanaka Y, et al. Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphologic study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. Virchows Arch Pathol Anat. 1985;406:45-58. (Pubitemid 15083760)
54. Zen Y, Aishima S, Ajioka Y, et al. Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement. Pathol Int. 2005;55:80-188.
55. Nakanuma Y, Harada K, Ishikawa A, et al. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2003;10:265-281. (Pubitemid 37407516)
56. Zen Y, Sasaki M, Fujii T, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct: an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol. 2006;44:350-358. (Pubitemid 43069217)
57. Nakanishi Y, Zen Y, Kondo S, et al. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Hum Pathol. 2008;39:1153-1161.
58. Cheng MS, AhChong AK, et al. Two cases of biliary papillomatosis with unusual associations. J Gastroenterol Hepatol. 1999;14:464-467. (Pubitemid 29256182)
59. Lee PSF, AuYeung KM, To KF, et al. Biliary papillomatosis complicating recurrent pyogenic cholangitis. Clin Radiol. 2001;56:591-593. (Pubitemid 35023773)
60. Chen TC, Nakanuma Y, Zen Y, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology. 2001;34:651-658. (Pubitemid 32927987)
61. Nakanuma Y, Sasaki M, Ishikawa A, et al. Biliary papillary neoplasm of the liver. Histol Histopathol. 2002;17:851-861. (Pubitemid 34784668)
62. D'Abrigeon G, Blanc P, Bauret P, et al. Diagnostic and therapeutic aspects of endoscopic retrograde cholangiography in papillomatosis of the bile ducts: analysis of five cases. Gastrointest Endosc. 1997;46:237-2243.
63. Kim YS, Myung SJ, Kim SY, et al. Biliary papillomatosis: clinical, cholangiograhic and cholangioscopic findings. Endoscopy. 1998;30:763-767. (Pubitemid 29041552)
64. Tsui WM, Lam PW, Mak CK, et al. Fine needle aspiration cytologic diagnosis of intrahepatic biliary papillomatosis (intraductal papillary tumor): report of three cases and comparative study with cholangiocarcinoma. Diagn Cytopathol. 2000;22:293-298. (Pubitemid 30220203)
65. Nakanuma Y, Yamaguchi K, Ohta K, et al. Pathology of hepatolithiasis in Japan. J Biliary Tract Pancreas. 1989;10:1301-1310.
66. Ludwig J, MacCarty RL, LaRusso NF, et al. Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis. Hepatology. 1986;6:560-568. (Pubitemid 16038169)
67. Stunell H, Buckley O, Geoghegan T, et al. Recurrent pyogenic cholangitis due to chronic infestation with Clonorchis sinensis. Eur Radiol. 2006;16:2612-2614. (Pubitemid 44649712)
68. Glenn F, Moody FG. Intrahepatic calculi. Ann Surg. 1961;153:711-724.
69. Nakayama F, Soloway RD, Nakayama T, et al. Hepatolithiasis in East Asia. Retrospective study. Dig Dis Sci. 1986;31:21-26.
70. Maki T. Pathogenesis of calcium bilirubinate gallstone. Role of E.coli. beta-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann Surg. 1966;164:90-100.
71. Chou ST, Gibson JB. Experimental cholangitis and cholelithiasis. Br J Exp Pathol. 1968;49:565-573.
72. Matsushiro T, Suzuki N, Sato T, et al. Effects of diet on glucaric acid concentration in bile and the formation of calcium bilirubinate gallstones. Gastroenterology. 1977;72:630-633. (Pubitemid 8097602)
73. Cetta FM. Bile infection documented as the initial event in the pathogenesis of brown pigment biliary stones. Hepatology. 1986;6:482-489. (Pubitemid 16086641)
74. Kim HG, Han J, Kim MH, et al. Prevalence of clonorchiasis in patients with gastrointestinal disease: a Korean nationwide multicenter survey. World J Gastroenterol. 2009;15:86-94.
75. Huang MH, Chen CH, Yen CM, et al. Relation of hepatolithiasis to helminthic infestation. J Gastroenterol Hepatol. 2005;20:141-146.
76. Sasaki M, Nakanuma Y, Kim YS. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology. 1998;27:54-61. (Pubitemid 28041534)
77. Shoda J, Oda K, Suzuki H, et al. Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients of with intrahepatic calculi. Hepatology. 2001;33:1194-1205. (Pubitemid 32378220)
78. Strichartz SD, Abedin MZ, Ippoliti AF, et al. Intrahepatic cholesterol stones: a rationale for dissolution therapy. Gastroenterology. 1991;72:630-633.
79. Ros E, Navarro S, Bru C, et al. Ursodeoxycholic acid treatment of primary hepatolithiasis in Caroli's syndrome. Lancet. 1993;342:404-406. (Pubitemid 23236356)